About SOTIO
SOTIO is a company based in Prague (Czechia) founded in 2010 was acquired by PPF Group in June 2012. It operates as a Professional Services. SOTIO has completed 1 acquisition, including CytunePharma. SOTIO offers products and services including SOT106, SOT109, and Nanrilkefusp alfa. SOTIO operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others.
- Headquarter Prague, Czechia
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sotio Biotech A.S.
-
Annual Revenue
$8.12 K (USD)0as on Dec 31, 2021
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
-
Acquired by
PPF Group
(Jun 01, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SOTIO
SOTIO offers a comprehensive portfolio of products and services, including SOT106, SOT109, and Nanrilkefusp alfa. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
SOT106 is developed as an ADC targeting LRRC15.
SOT109 is designed to target cadherin-17 in cancers.
Nanrilkefusp alfa is developed for targeted immune activation.
Unlock access to complete
Unlock access to complete
Funding Insights of SOTIO
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SOTIO
SOTIO has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include PPF Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PPF Group is engaged in international investment across diverse sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SOTIO
SOTIO has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CytunePharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Immunostimulatory agents and conjugated monoclonal antibodies for cancer are developed.
|
2007 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - SOTIO
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sotio Comparisons
Competitors of SOTIO
SOTIO operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sotio
Frequently Asked Questions about SOTIO
When was SOTIO founded?
SOTIO was founded in 2010.
Where is SOTIO located?
SOTIO is headquartered in Prague, Czechia.
Who is the current CEO of SOTIO?
Radek Spisek is the current CEO of SOTIO.
What is the annual revenue of SOTIO?
Annual revenue of SOTIO is $8.12K as on Dec 31, 2021.
What does SOTIO do?
SOTIO Biotech is engaged in the development of next-generation immunotherapies for cancer treatment. The companys pipeline includes internally developed and in-licensed candidates targeting various solid tumor types. Solutions such as antibody-drug conjugates and immunocytokines are being advanced through clinical development to provide safer and more effective treatments. The focus is placed on translating scientific innovation into patient benefits within the oncology sector.
Who are the top competitors of SOTIO?
SOTIO's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
What products or services does SOTIO offer?
SOTIO offers SOT106, SOT109, and Nanrilkefusp alfa.
How many acquisitions has SOTIO made?
SOTIO has made 1 acquisition, including CytunePharma.
Who are SOTIO's investors?
SOTIO has 1 investor. Key investors include PPF Group.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.